A unique antinucleic acid approach to the mass screening of antimalarial drugs.
D000818:Animals; D000962:Antimalarials / Q000494:pharmacology*; D002462:Cell Membrane / Q000187:drug effects; D055598:Chemical Phenomena; D002621:Chemistry; D002738:Chloroquine / Q000494:pharmacology; D003201:Computers; D004269:DNA, Bacterial / Q000037:antagonists & inhibitors / Q000378:metabolism*; D004912:Erythrocytes / Q000187:drug effects; D006863:Hydrogen-Ion Concentration; D009705:Nucleosides / Q000378:metabolism; D010600:Pharmacology; D010961:Plasmodium / Q000187:drug effects*; D011319:Primaquine / Q000494:pharmacology; D011739:Pyrimethamine / Q000494:pharmacology; D011796:Quinacrine / Q000494:pharmacology; D011803:Quinine / Q000494:pharmacology; D012329:RNA, Bacterial / Q000037:antagonists & inhibitors / Q000378:metabolism*; D051381:Rats; D013450:Sulfones / Q000494:pharmacology; D013696:Temperature; D014316:Tritium
D000962:Antimalarials; D004269:DNA, Bacterial; D009705:Nucleosides; D012329:RNA, Bacterial; D013450:Sulfones; D014316:Tritium; D002738:Chloroquine; D011803:Quinine; D011796:Quinacrine; D011319:Primaquine; D011739:Pyrimethamine